To The Moon

Joel Hawthorne @louiswinthrop updates us on Friday's activity in $TSLA, $NVDA, $MSFT, $AMD, $AAPL, and today's $VIX and ...TSLA Leads Equity OptionsFrom Youtube: https://www.youtube.com/watch?v=M2ZjbjhBE3A

3.25% dividend yield, strong free cash generation.Oak Street acquisition projected to add $2 billion in EBITDA by 2026.Expects significant volume growth at pharmacies with the introduction of several biosimilar and generic drugs in FY23.Modest FY23 guidance targeting 7% EPS growth despite some sustained headwinds in retail.Investment ThesisCVS Health$CVS Health(CVS)$ is a well-known retail pharmacy chain in the United States that has expanded into healthcare services with Aetna and is targeting Medicare Advantage and Medicaid recipients. In a recent acquisition in the form of Oak Street, CVS will continue this trend.85% of the US population lives within 10 miles of a CVS, and the number of digital customers getting care under CVS Health has increas

Tesla is full of distractions, but don't let the headlines impede your view on how the business is really performing.

Fourth-quarter earnings season continues this week, with close to 90 S&P 500 companies scheduled to

A key point of conflict requires resolutionInvestors can be excused for feeling a sense of confusion

The stock market rally marched higher as the Fed took a slightly more dovish stance, even though it

Apple Inc.'s business came under pressure in the holiday quarter, as the company posted a 5% decline

US jobs report may point to possible soft landing for economyECB, BOE seen raising rates while Brazi

Speculators' love of wagering on Tesla Inc. has propelled Elon Musk's electric-vehicle maker into on